• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳腺肿瘤中的Ki-67免疫染色及其与预后的关系。

Ki-67 immunostaining in human breast tumors and its relationship to prognosis.

作者信息

Wintzer H O, Zipfel I, Schulte-Mönting J, Hellerich U, von Kleist S

机构信息

Institute of Immunobiology, University of Freiburg, Federal Republic of Germany.

出版信息

Cancer. 1991 Jan 15;67(2):421-8. doi: 10.1002/1097-0142(19910115)67:2<421::aid-cncr2820670217>3.0.co;2-q.

DOI:10.1002/1097-0142(19910115)67:2<421::aid-cncr2820670217>3.0.co;2-q
PMID:1845945
Abstract

Ki-67 labeling was quantified in 37 nonmalignant breast tissues and in 63 breast carcinomas by counting ten random high-power fields each in three section planes (RC) or by evaluation of the area with the highest labeling density (HDC). Both procedures proved to be highly correlated (rs = 0.94). Ki-67-positive fractions of the nonmalignant tissues (mean, 2.1% for RC and 4.1% for HDC) were significantly lower as compared with the carcinomas (mean, 14.5% for RC and 17.5% for HDC). In carcinomas the Ki-67 labeling was significantly associated with pT stage, axillary lymph node status, and tumor grading and inversely related to progesterone receptor status. Using the medians of both counting methods (12% for RC and 17% for HDC) as cutoff points, significantly different curves for overall and disease-free survival (median follow-up, 37 months) were obtained. However, Cox multivariate analysis failed to demonstrate an independent effect of Ki-67 labeling. In contrast, Ki-67 reactivity seems to be of independent prognostic value if a higher cutoff level was selected.

摘要

通过在三个切片平面(RC)中各计数十个随机高倍视野,或通过评估标记密度最高的区域(HDC),对37例非恶性乳腺组织和63例乳腺癌组织中的Ki-67标记进行定量分析。两种方法的结果高度相关(rs = 0.94)。与癌组织相比,非恶性组织的Ki-67阳性率(RC法平均为2.1%,HDC法平均为4.1%)显著更低(癌组织RC法平均为14.5%,HDC法平均为17.5%)。在癌组织中,Ki-67标记与pT分期、腋窝淋巴结状态及肿瘤分级显著相关,与孕激素受体状态呈负相关。以两种计数方法的中位数(RC法为12%,HDC法为17%)作为截断点,得出了总生存期和无病生存期(中位随访时间37个月)的显著不同曲线。然而,Cox多因素分析未能证明Ki-67标记具有独立影响。相反,如果选择更高的截断水平,Ki-67反应性似乎具有独立的预后价值。

相似文献

1
Ki-67 immunostaining in human breast tumors and its relationship to prognosis.人乳腺肿瘤中的Ki-67免疫染色及其与预后的关系。
Cancer. 1991 Jan 15;67(2):421-8. doi: 10.1002/1097-0142(19910115)67:2<421::aid-cncr2820670217>3.0.co;2-q.
2
Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis.Ki-67免疫染色在Ⅰ/Ⅱ期淋巴结阴性乳腺癌中的表达。与预后显著相关。
Cancer. 1991 Aug 1;68(3):549-57. doi: 10.1002/1097-0142(19910801)68:3<549::aid-cncr2820680318>3.0.co;2-j.
3
Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer.免疫增殖标志物Ki-S2作为淋巴结阴性乳腺癌的预后指标
J Natl Cancer Inst. 1999 Feb 3;91(3):271-8. doi: 10.1093/jnci/91.3.271.
4
Growth fraction in breast carcinoma determined by Ki-67 immunostaining: correlation with pathological and clinical variables.
Gynecol Obstet Invest. 1992;33(1):47-50. doi: 10.1159/000294846.
5
The Long-term Prognostic Performance of Ki-67 in Primary Operable Breast Cancer and Evaluation of Its Optimal Cutoff Value.Ki-67在原发性可手术乳腺癌中的长期预后性能及其最佳临界值评估
Appl Immunohistochem Mol Morphol. 2016 Mar;24(3):159-66. doi: 10.1097/PAI.0000000000000164.
6
Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.浸润性淋巴细胞、肿瘤特征与早期乳腺癌患者复发。
Am J Clin Oncol. 2013 Jun;36(3):224-31. doi: 10.1097/COC.0b013e3182467d90.
7
Relationship of necrosis and tumor border to lymph node metastases and 10-year survival in carcinoma of the breast.
Am J Surg Pathol. 1978 Mar;2(1):39-46. doi: 10.1097/00000478-197803000-00005.
8
p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.乳腺癌中p53和c-erbB-2蛋白表达。一项免疫组织化学研究,包括与人类乳腺癌受体状态、增殖标志物及临床分期的相关性。
Am J Clin Pathol. 1992 Oct;98(4):408-18. doi: 10.1093/ajcp/98.4.408.
9
Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.乳腺癌细胞动力学:通过单克隆抗体Ki-67免疫细胞化学测定生长分数及其与流式细胞术S期以及肿瘤侵袭性某些特征的相关性。
Anticancer Res. 1991 Nov-Dec;11(6):2015-21.
10
Monoclonal antibody NCRC 11 reactivity with advanced breast carcinoma: lack of prognostic value.单克隆抗体NCRC 11与晚期乳腺癌的反应性:缺乏预后价值。
Histopathology. 1988 Dec;13(6):695-7. doi: 10.1111/j.1365-2559.1988.tb02100.x.

引用本文的文献

1
Aptamer-guided graphene oxide quantum dots for targeted suicide gene therapy in an organoid model of luminal breast cancer.适体引导氧化石墨烯量子点在腔面乳腺癌类器官模型中的靶向自杀基因治疗。
Sci Rep. 2024 Oct 15;14(1):24104. doi: 10.1038/s41598-024-74312-9.
2
Establishment of a logistic regression model nomogram for clinicopathological characteristics and risk factors with axillary lymph node metastasis in T1 locally advanced breast cancer: a retrospective study.建立T1期局部晚期乳腺癌腋窝淋巴结转移的临床病理特征及危险因素的逻辑回归模型列线图:一项回顾性研究。
Gland Surg. 2024 Jun 30;13(6):871-884. doi: 10.21037/gs-24-34. Epub 2024 Jun 27.
3
An analysis of Ki-67 expression in stage 1 invasive ductal breast carcinoma using apparent diffusion coefficient histograms.
利用表观扩散系数直方图分析Ⅰ期浸润性导管乳腺癌中Ki-67的表达情况。
Quant Imaging Med Surg. 2021 Apr;11(4):1518-1531. doi: 10.21037/qims-20-615.
4
Quantitative assessment of Ki67 expression in correlation with various breast cancer characteristics and survival rate; cross sectional study.Ki67表达与各种乳腺癌特征及生存率相关性的定量评估;横断面研究。
Ann Med Surg (Lond). 2019 Nov 17;48:129-134. doi: 10.1016/j.amsu.2019.11.005. eCollection 2019 Dec.
5
A retrospective, single-center cohort study on 65 patients with primary retroperitoneal liposarcoma.一项针对65例原发性腹膜后脂肪肉瘤患者的回顾性单中心队列研究。
Oncol Lett. 2018 Feb;15(2):1799-1810. doi: 10.3892/ol.2017.7533. Epub 2017 Dec 5.
6
High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium.高通量自动化评分 Ki67 在乳腺癌组织微阵列从乳腺癌协会联盟。
J Pathol Clin Res. 2016 Apr 6;2(3):138-53. doi: 10.1002/cjp2.42. eCollection 2016 Jul.
7
Effects of Copper, Zinc, and Vitamin Complex (Cernevit®) on Hepatic Healing in Rats Experimentally Subjected to Blunt Hepatic Trauma.铜、锌和复合维生素(Cernevit®)对实验性钝性肝损伤大鼠肝脏愈合的影响。
Indian J Surg. 2015 Dec;77(Suppl 3):1045-9. doi: 10.1007/s12262-014-1128-0. Epub 2014 Jun 25.
8
Ki-67 and caspase expression in breast carcinoma: does variance in locational sampling exist?乳腺癌中Ki-67和半胱天冬酶的表达:是否存在定位取样差异?
Int J Clin Exp Pathol. 2015 Sep 1;8(9):11305-13. eCollection 2015.
9
Correlation between conductivity and prognostic factors in invasive breast cancer using magnetic resonance electric properties tomography (MREPT).使用磁共振电特性断层扫描(MREPT)评估浸润性乳腺癌电导率与预后因素之间的相关性。
Eur Radiol. 2016 Jul;26(7):2317-26. doi: 10.1007/s00330-015-4067-7. Epub 2015 Oct 23.
10
Prognostic value of ki-67 in breast carcinoma: tissue microarray method versus whole section analysis- potentials and pitfalls.Ki-67在乳腺癌中的预后价值:组织微阵列法与全切片分析——潜力与陷阱
Pathol Oncol Res. 2015 Apr;21(2):315-24. doi: 10.1007/s12253-014-9823-5. Epub 2014 Aug 6.